ClinicalTrialsFinder

GC/GEJC Clinical Trials in Tianjin, Tianjin Municipality

1 recruitingTianjin, Tianjin Municipality, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC)

Adebrelimab (SHR-1316)XELOXGC/GEJC
Tianjin Medical University Cancer Institute and Hospital25 enrolled1 locationNCT06506292